Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours

PURPOSE: To determine the utility of the 2022 WHO Classification of pituitary tumours in routine clinical practice and to develop an optimal diagnostic algorithm for evaluation of tumour type in a real-world setting. METHODS: Retrospective evaluation of pituitary tumour immunohistochemistry (IHC), o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenders, N. F., Chui, J., Low, J., Inder, W. J., Earls, P. E., McCormack, A. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675696/
https://www.ncbi.nlm.nih.gov/pubmed/36271964
http://dx.doi.org/10.1007/s11102-022-01284-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675696/
https://www.ncbi.nlm.nih.gov/pubmed/36271964
http://dx.doi.org/10.1007/s11102-022-01284-2

Ejemplares similares